Intimation regarding conference call organised by ICICI Securities (Q2FY27 Results Conference Call) to be held on Monday, November 02, 2026, at 04:30 p.m.
Extract of Financial Result for the period ended on 30.09.2026
Financial Results
Results Disclosure
Transcript of presentation on the unaudited financial results (Consolidated and Standalone) for the quarter and half year ended September 30, 2026
The Stock Exchange and stakeholders are requested to take on record, Intimation pertaining to New ISIN of the Company.
UNIT ALLOTTED FOR SENSEX ETF DT 24-09-2026
Cessation of Mr. Suresh P Manglani as Executive Director and Key Managerial Personnel of the Company upon his superannuation w.e.f. closure of business hours on 31st October 2026
Outcome of Board Meeting - Scheme of Arrangement.
Outcome of the Board Meeting held on 22nd October 2026 - Change in Director
AESL delivers Record Q2 Performance, Sustains Strong Growth Momentum
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 22, 2026 for Deepak Kumar Singal
Financial Results
Results Disclosure
We wish to inform you that Board of Directors has approved the Unaudited Financial Results (Standalone) along with Limited Review Report for the quarter and half year ended September 30, 2026, as recommended by Audit Committee.
The company has fixed Regulation 60(2) Record Date Interest Payment / Redemption / Dividend for the purpose of
Appointment of Sh. Anand Saklecha as a Non-Official (Independent) Director of CONCOR
As per Attachment
Copy of notice.
UNIT ALLOTTED FOR SENSEX ETF DT 23-09-2026
Outcome of Board Meeting.
Certificate confirming payment of interest w.r.t. NCD bearing ISIN: INE296G07218
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for LCI Estates LLP & Others
Please refer the enclosed file.
Board Meetings
Results Disclosure
Hindustan Organic Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for Q2 of FY 2026-27 and other routine agenda.
attached herewith outcome of board meeting of the company
Cancellation of Analyst/Institutional Investor Meet scheduled to be held on October 23, 2026
Financial Results
Results Disclosure
Unaudited Financial Results for the quarter and half year ended 30th September 2026
Lenskart Solutions Limited has informed the Exchange about schedule of Earnings Call for the quarter and half year ended September 30, 2026
